James Bush Selected Research

human TGFB3 protein

11/2010	Scar-improving efficacy of avotermin administered into the wound margins of skin incisions as evaluated by a randomized, double-blind, placebo-controlled, phase II clinical trial.
4/2009	Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies.
4/2009	A new approach for the prophylactic improvement of surgical scarring: avotermin (TGF beta 3).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James Bush Research Topics

Disease

4	Cicatrix (Scar) 05/2013 - 04/2009
3	Wounds and Injuries (Trauma) 05/2013 - 04/2009
1	Infections 01/2019
1	Inflammation (Inflammations) 05/2013
1	Erythema 04/2009

Drug/Important Bio-Agent (IBA)

3	human TGFB3 proteinIBA 11/2010 - 04/2009
2	Transforming Growth Factor beta3 (TGF beta 3)IBA 04/2009 - 04/2009
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	CytokinesIBA 05/2013
1	Interleukin-10 (Interleukin 10)IBA 05/2013
1	Interleukin-4 (Interleukin 4)IBA 05/2013
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2010
1	CollagenIBA 04/2009
1	Biological ProductsIBA 04/2009

Therapy/Procedure

1	Injections 11/2010
1	Intradermal Injections 11/2010
1	Therapeutics 04/2009